Stock Analysis tagged as

Sector - Healthcare and Social Assistance

  • Showing 101-146 of 146 items
  • <<
  • 1
  • 2
  1. Overlooked Israel Is A Portfolio Growth Engine

  2. The Celtic Tiger Roars Once Again

  3. The REIT Play In Healthcare

  4. Valeant Eyes Bausch & Lomb

  5. Roche, Reloaded

  6. Elan Continues To Make Baffling Strategic Decision

  7. After A Big Rally, Pfizer Might Need Some Rest

  8. Adasuve Deal Is Very Good For Alexza, But What About Teva?

  9. Recent Financials May Not Be Entirely Fair To Hologic

  10. Amgen Chased By The Bubble

  11. Teva Still Too Cheap, But Still Too Uncertain

  12. It Gets A Little Harder From Here For Covidien

  13. Thermo Steps Up And Seals A Deal For Life Technologies

  14. Broad Weakness Makes It Harder To Like St. Jude Today

  15. Pharma Is Doing All The Pulling For Johnson & Johnson

  16. 4 ETFs To Play A Booming Healthcare Sector

  17. Pfizer Readies Zoetis For Market

  18. Herbalife Is Merely A Pawn In This Hedge Fund Battle Royal

  19. Abbott Labs Spins Off AbbVie: Which Is The Better Buy?

  20. A Look Back At The Year In Pharmaceuticals

  21. A Look Back At The Year In Medical Technology

  22. A Look Back At The Year In Biotech

  23. A Triple Play Of Biotech Disappointments Last Week

  24. How Far Can Philips' Turnaround Take The Stock?

  25. Smith & Nephew's Costly Deal

  26. Endo Health Solutions Needs Some Solutions Of Its Own

  27. Bayer Buys Schiff Nutrition International: Winners All Around

  28. Is “Less Bad” As Good As It Gets For Dendreon?

  29. Drugs Have Moved J&J On To A New Phase

  30. Danaher Does Another Typical Danaher Deal

  31. The Week In Healthcare

  32. Investor Unrest Leads The WellPoint CEO To Resign

  33. Pfizer Looks To Spin Off Animal Health Unit

  34. The Week Ahead In Healthcare

  35. The Week Ahead In Healthcare

  36. More Healthy Alternatives To Zimmer

  37. Hi-Tech Pharmacal An Under Followed Name Worth Following

  38. WellPoint Buys More Medicaid Exposure

  39. Lincare Shows That You Can Go Home Again

  40. Can Body Sculpting Bulk Up Solta Medical?

  41. Medicine Gets Personalized

  42. Bio-Reference Labs Taking Advantage Of Esoteric Opportunities

  43. Want A High-Yield Healthcare Stock? Look To Canada

  44. Stocks On Fire As The Market Bounces

  45. AmerisourceBergen Looks Very Healthy

  46. Lifepoint Hospitals Heads For The Country

  47. Becton Dickinson Safe And Steady

  48. Davita Goes Shopping

  49. Stocks That Keep You Looking Good

  50. Market-Crushing ETFs

  51. A Healthy Growth Strategy

  52. Control May Be Herbalife's Real Long-Term Problem

  53. Premium-Price athenahealth Leaves Little Room For Error

  54. Obagi Puts Its Problems Behind It

  55. Stocks Showing Resilience

  56. ilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company

  57. Top Rated Highly Shorted Stocks

  58. AstraZeneca Searches For Answers

  59. LabCorp Fighting Industry Headwinds

  60. Healthcare Services Group - Great Business … Great Stock?

  61. Smart Stocks To Rally With

  62. A Strong Prognosis For Healthcare REITs

  63. Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?

  64. Wall Street Isn't Buying The Medifast Story

  65. Stocks For An Uncertain World

  66. LabCorp Passes the Test

  67. Transcend Services: A Physician's Best Friend

  68. Pfizer Shrugs Off the Loss Of Lipitor

  69. The Long-Term Play In Lab Work

  70. 4 Overbought Stocks To Watch

  71. Europe Won't Kill Siemens

  72. Best S&P 500 Stocks Of 2011

  73. Slow And Steady ETFs Outperforming

  74. 4 Heavily Shorted Stocks That Could Climb Higher

  75. 4 ETFs On Fire Right Now

  76. The War Against Alzheimer's Requires Thinking Small

  77. 2011's Biggest Mergers and Acquisitions

  78. Neogen Is Almost Cheap

  79. How Intuitive Surgical Justifies Its Lofty Valuation

  80. 2011 In Review - Pharmaceuticals

  81. 2011 - Another Sick Year For Larger Med-Tech

  82. 2011 In Review - The Best-Performing ETFs

  83. Hill-Rom: Litigation Equals Opportunity For Investors

  84. Sanofi's Investment Prospects

  85. SonoSite Finds Its Deal

  86. Will Qiagen's Restructuring Address The Real Problems?

  87. Covidien Delivers Once Again

  88. Meridian Biosciences – Stealth Income Play

  89. Is Hologic A Coiled Spring?

  90. If CareFusion Can Execute, This Is A Major Bargain

  91. CVS Shows Its Resilience In Any Economy

  92. Biogen Idec Has Built A Valuable Franchise

  93. No Rattle At HUM

  94. Zimmer Looking To Escape Its Value Trap

  95. VCA Antech Cut Down To Value

  96. Stryker Scraping By

  97. Abbott Labs Joins The Separation Movement

  98. High Yielding Equities

  99. 3 Reasons To Own Lincare Holdings

  100. PPD Goes Private

  • Showing 101-146 of 146 items
  • <<
  • 1
  • 2
Trading Center